HIV is prevalent in Sub-Saharan Africa, and depression frequently co-occurs. Depression is one of the most important predictors of poor adherence to antiretroviral therapy (ART). Little has been done to develop integrated interventions that are feasible and appropriate for task-shifting to nonspecialists that seek to address both depression and barriers to ART adherence in Sub-Saharan Africa. This case series describes an integrated intervention for depression and ART adherence delivered by a lay adherence counselor and supervised by a local psychologist. The 6-session intervention was based on problem-solving therapy for depression and for barriers to adherence (PST-AD), with stepped care for those whose depression did not recover with PST...
Depression is prevalent among people living with HIV in South Africa and interferes with adherence t...
Background: Depression is highly prevalent among patients newly starting antiretroviral treatment (A...
BACKGROUND:Depression is highly prevalent among patients newly starting antiretroviral treatment (AR...
Using a pilot trial design in an HIV care clinic in Zimbabwe, we randomised 32 adults with poor adhe...
INTRODUCTION: Non-adherence to antiretroviral therapy (ART) is the main cause of viral non-suppressi...
Using a pilot trial design in an HIV care clinic in Zimbabwe, we randomised 32 adults with poor adhe...
Depression affects 18-30% of HIV-infected patients in Africa and is associated with greater stigma, ...
Depression affects 18-30% of HIV-infected patients in Africa and is associated with greater stigma, ...
BACKGROUND: Depression is highly prevalent among patients newly starting antiretroviral treatment (A...
BACKGROUND: There is limited evidence that interventions for depression and other common mental diso...
Background Depression is highly prevalent among patients newly starting antiretroviral treatment (AR...
Depression is highly prevalent among people living with HIV in Malawi and elsewhere in sub-Saharan A...
As antiretroviral therapy (ART) for HIV becomes increasingly available in low and middle income coun...
Background: As antiretroviral therapy (ART) for HIV becomes increasingly available in low and middle...
Background: Depression is highly prevalent among patients newly starting antiretroviral treatment (A...
Depression is prevalent among people living with HIV in South Africa and interferes with adherence t...
Background: Depression is highly prevalent among patients newly starting antiretroviral treatment (A...
BACKGROUND:Depression is highly prevalent among patients newly starting antiretroviral treatment (AR...
Using a pilot trial design in an HIV care clinic in Zimbabwe, we randomised 32 adults with poor adhe...
INTRODUCTION: Non-adherence to antiretroviral therapy (ART) is the main cause of viral non-suppressi...
Using a pilot trial design in an HIV care clinic in Zimbabwe, we randomised 32 adults with poor adhe...
Depression affects 18-30% of HIV-infected patients in Africa and is associated with greater stigma, ...
Depression affects 18-30% of HIV-infected patients in Africa and is associated with greater stigma, ...
BACKGROUND: Depression is highly prevalent among patients newly starting antiretroviral treatment (A...
BACKGROUND: There is limited evidence that interventions for depression and other common mental diso...
Background Depression is highly prevalent among patients newly starting antiretroviral treatment (AR...
Depression is highly prevalent among people living with HIV in Malawi and elsewhere in sub-Saharan A...
As antiretroviral therapy (ART) for HIV becomes increasingly available in low and middle income coun...
Background: As antiretroviral therapy (ART) for HIV becomes increasingly available in low and middle...
Background: Depression is highly prevalent among patients newly starting antiretroviral treatment (A...
Depression is prevalent among people living with HIV in South Africa and interferes with adherence t...
Background: Depression is highly prevalent among patients newly starting antiretroviral treatment (A...
BACKGROUND:Depression is highly prevalent among patients newly starting antiretroviral treatment (AR...